Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
5,086,994
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
276,386
-
Shares change
-
-43,765
-
Total reported value, excl. options
-
$254,142
-
Value change
-
-$21,440
-
Number of buys
-
6
-
Number of sells
-
7
-
Price
-
$0.8901
Institutional Holders of Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) as of Q2 2025
As of 30 Jun 2025 Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 276,386 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Sargent Investment Group, LLC, Holos Integrated Wealth LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and RAYMOND JAMES FINANCIAL INC.
This table shows 24 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.